Vanda Pharmaceuticals (VNDA) Shareholder's Equity Growth (1y) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Vanda Pharmaceuticals | 379.35 Mn | 177.04 Mn | 48.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -45.10% |
| Dec 31, 2025 | -39.25% |
| Sep 30, 2025 | -13.90% |
| Jun 30, 2025 | -10.36% |
| Mar 31, 2025 | -5.99% |
| Dec 31, 2024 | -1.17% |
| Sep 30, 2024 | -0.35% |
| Jun 30, 2024 | 0.48% |
| Mar 31, 2024 | 1.54% |
| Dec 31, 2023 | 3.36% |
| Sep 30, 2023 | 5.32% |
| Jun 30, 2023 | 6.16% |
| Mar 31, 2023 | 6.69% |
| Dec 31, 2022 | 4.41% |
| Sep 30, 2022 | 4.53% |
| Jun 30, 2022 | 5.68% |
| Mar 31, 2022 | 7.38% |
| Dec 31, 2021 | 11.40% |
| Sep 30, 2021 | 11.97% |
| Jun 30, 2021 | 11.50% |
| Mar 31, 2021 | 12.31% |
| Dec 31, 2020 | 10.30% |
| Sep 30, 2020 | 9.89% |
| Jun 30, 2020 | 45.46% |
| Mar 31, 2020 | 49.56% |
| Dec 31, 2019 | 49.21% |
| Sep 30, 2019 | 53.36% |
| Jun 30, 2019 | 18.08% |
| Mar 31, 2019 | 15.45% |
| Dec 31, 2018 | 109.63% |
| Sep 30, 2018 | 100.37% |
| Jun 30, 2018 | 91.20% |
| Mar 31, 2018 | 88.18% |
| Dec 31, 2017 | 0.04% |
| Sep 30, 2017 | 1.01% |
| Jun 30, 2017 | 8.06% |
| Mar 31, 2017 | 4.17% |
| Dec 31, 2016 | -1.28% |
| Sep 30, 2016 | -11.49% |
| Jun 30, 2016 | -18.79% |
| Mar 31, 2016 | -19.32% |
| Dec 31, 2015 | -17.28% |
| Sep 30, 2015 | 13,628.79% |
| Jun 30, 2015 | 16,820.56% |
| Mar 31, 2015 | 626.65% |
| Dec 31, 2014 | 264.47% |
| Sep 30, 2014 | -97.87% |
| Jun 30, 2014 | -82.39% |
| Mar 31, 2014 | 223.76% |
| Dec 31, 2013 | 345.47% |
| Sep 30, 2013 | 225.70% |
| Jun 30, 2013 | -74.98% |
| Mar 31, 2013 | -75.92% |
| Dec 31, 2012 | -70.41% |
| Sep 30, 2012 | -59.26% |
| Jun 30, 2012 | -49.20% |
| Dec 31, 2011 | -11.28% |
| Dec 31, 2010 | 63.83% |